ZIM Laboratories approved audited standalone and consolidated financial results for Q4 and FY ended 31 March 2026, reporting a significant decline in annual profit.
Consolidated net profit fell 52% YoY to ₹583.81 lakhs, while standalone net profit declined 49% YoY to ₹596.52 lakhs for FY26.
The company appointed M/s Dhananjay V. Joshi & Associates as Cost Auditor for FY 2026-27 and received unmodified audit opinions from Deloitte.
Cash position improved significantly with consolidated cash reaching ₹2,512.19 lakhs, up from ₹194.66 lakhs in the previous year.